While the top- and bottom-line numbers for Globe Life (GL) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Globe Life (GL) came out with quarterly earnings of $3.14 per share, beating the Zacks Consensus Estimate of $3.10 per share. This compares to earnings of $2.80 per share a year ago.
Life and supplemental health insurance firm Globe Life reported an increase in fourth-quarter profit on Wednesday, driven by stronger underwriting performance and higher income from investments.
Globe Life Inc.'s 4.250% Junior Subordinated Debentures GL-D offer a compelling investment with a 7.24% Yield to Maturity and a BBB+ credit rating. Despite a short report-induced price drop in April 2024, Globe Life's stock has recovered, reaffirming investor's confidence in the stability of the company. GL-D is undervalued compared to Globe Life's OTC bonds and offers the highest yield to maturity among similar baby bonds in the sector.
Globe Life demonstrates steady EPS growth due to disciplined underwriting and cost efficiency. The company targets lower to middle-income families, maintaining stable annualized premiums and high underwriting margins. Globe Life's strong liquidity, high RBC ratio, and quality investment portfolio bolster its financial health.
NEW YORK CITY, NY / ACCESSWIRE / January 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Globe Life Inc. ("Globe Life" or "the Company") (NYSE:GL). Investors who purchased Globe Life securities prior to May 8, 2019, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/GL.
NEW YORK CITY, NY / ACCESSWIRE / January 13, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Globe Life Inc. ("Globe Life" or "the Company") (NYSE:GL). Investors who purchased Globe Life securities prior to May 8, 2019, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/GL.
NEW YORK CITY, NY / ACCESSWIRE / January 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Globe Life Inc. ("Globe Life" or "the Company") (NYSE:GL). Investors who purchased Globe Life securities prior to May 8, 2019, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/GL.
GL stock rallies on premium growth, higher invested assets, favorable return on capital and financial flexibility as well as effective capital deployment.
NEW YORK CITY, NY / ACCESSWIRE / January 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Globe Life Inc. ("Globe Life" or "the Company") (NYSE:GL). Investors who purchased Globe Life securities prior to May 8, 2019, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/GL.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
NEW YORK CITY, NY / ACCESSWIRE / January 9, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Globe Life Inc. ("Globe Life" or "the Company") (NYSE:GL). Investors who purchased Globe Life securities prior to May 8, 2019, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/GL.